Effects of Adiponectin on Mortality and Its Mechanism in a Sepsis Mouse Model

REFERENCES

• Opal SM, Fisher CJ, Jr, Dhainaut JF, Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group. Crit Care Med. 1997;25:1115–1124.
   PubMed Web of Science ®Google Scholar
• Abraham E, Wunderink R, Silverman H, Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group. JAMA 1995;273:934–941.
   PubMed Web of Science ®Google Scholar
• Annane D, Bellissant E, Cavaillon JM. Septic shock. Lancet 2005;365:63.
   PubMed Web of Science ®Google Scholar
• Ouchi N, Walsh K. Adiponectin as an anti-inflammatory factor. Cin Chim Acta 2007;380(1–2):24–30.
   PubMed Web of Science ®Google Scholar
• Thakur V, Pritchard MT, McMullen MR, Adiponectin normalizes LPS-stimulated TNF-alpha production by rat Kupffer cells after chronic ethanol feeding. Am J Physiol Gastrointest Liver Physiol. 2006;290:G998–G1007.
   PubMed Web of Science ®Google Scholar
• Yokota T, Oritani K, Takahashi I, Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood 2000;96: 1723–1732.
   PubMed Web of Science ®Google Scholar
• Wulster-Radcliffe MC, Ajuwon KM, Wang J, Adiponectin differentially regulates cytokines in porcine macrophages. Biochem Biophys Res Commun. 2004; 316:924–929.
   PubMed Web of Science ®Google Scholar
• Uji Y, Yamamoto H, Tsuchihashi H, Adiponectin deficiency is associated with severe polymicrobial sepsis, high inflammatory cytokine levels, and high mortality. Surgery 2009;145:550–557.
   PubMed Web of Science ®Google Scholar
• Teoh H, Quan A, Bang KW, Adiponectin deficiency promotes endothelial activation and profoundly exacerbates sepsis-related mortality. Am J Physiol Endocrinol Metab. 2008;295:E658–E664.
   PubMed Web of Science ®Google Scholar
• Wang H, Yang H, Tracey KJ. HMGB1 as a late mediator of lethal systemic inflammation. Am J Respir Crit Care Med. 2001;164(10 Pt 1):1768–1773.
   PubMed Web of Science ®Google Scholar
• Bustin M. Regulation of DNA dependent activities by the functional motifs of the high-mobility-group chromosomal proteins. Mol Cell Biol. 1999;19:5237–5246.
   PubMed Web of Science ®Google Scholar
• Yang H, Wang H, Czura CJ, The cytokine activity of HMGB1. J Leukoc Biol. 2005;78:1–8.
   PubMed Web of Science ®Google Scholar
• Yang H, Tracey KJ. Targeting HMGB1 in inflammation. Biochim Biophys Acta 2010;1799(1–2):149–156.
   PubMed Web of Science ®Google Scholar
• Chaudry IH, Wichterman KA, Baue AE. Effect of sepsis on tissue adenine nucleotide levels. Surgery 1979;85: 205–211.
   PubMed Web of Science ®Google Scholar
• Karantonis FF, Nikiteas N, Perrea D, Evaluation of the effects of laparotomy and laparoscopy on the immune system in intra-abdominal sepsis—a review. J Invest Surg. 2008;21:330–339.
   PubMed Web of Science ®Google Scholar
• Freise H, Bruckner UB, Spiegel HU. Animal models of sepsis. J Invest Surg. 2001;14:195–212.
   PubMed Web of Science ®Google Scholar
• Peake PW, Shen Y, Campbell LV, Human adiponectin binds to bacterial lipopolysaccharide. Biochem Biophys Res Commun. 2006;341:108–115.
   PubMedGoogle Scholar
• Kuhns DB, Alvord WG, Gallin JI. Increased circulating cytokines, cytokine antagonists, and E-selectin after intravenous administration of endotoxin in human. J Infect Dis. 1995;171:145–152.
   PubMedGoogle Scholar
• Damas P, Reuter A, Gysen P, Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans. Crit Care Med. 1989;17:975–978.
   PubMed Web of Science ®Google Scholar
• Remick DG, Bolgos GR, Siddiqui J, Six at six: interleukin-6 measured 6 h after the initiation of sepsis predicts mortality over 3 days. Shock 2002;17:463–467.
   PubMed Web of Science ®Google Scholar
• Yang H, Ochani M, Li J, Reversing established sepsis with antagonists of endogenous high mobility group box 1. Proc Natl Acad Sci. 2004;101:296–301.
   PubMed Web of Science ®Google Scholar
• Wang H, Bloom O, Zhang M, HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999;285(5425):248–251.
   PubMed Web of Science ®Google Scholar
• Andersson U, Wang H, Palmblad K, High mobility group 1 protein (HMGB1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med. 2000;192:565–570.
   PubMed Web of Science ®Google Scholar
• Shao YM, Yao HG, Liang XZ, Relation between level of expression of high mobility group protein B1 in hepatic tissue with the severity and prognosis of sepsis in rats. Chinese Crit Care Med. 2006;18:668–672.
   Google Scholar
• Wolf AM, Wolf D, Rumpold H, Adiponectin induces tha anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes. Biochem Biophys Res Commun. 2004;323:630–635.
   PubMed Web of Science ®Google Scholar
• Tsuchihashi H, Yamamoto H, Maeda K, Circulating concentrations of adiponectin, an endogenous lipopolysaccharide neutralizing protein, decrease in rats with polymicrobial sepsis. J Surg Res. 2006;134:348–353.
   PubMedGoogle Scholar
• Folco EJ, Rocha VZ, Lopez-llasaca M, Adiponectin inhibits pro-inflammatory signaling in human macrophages independent of interleukin-10. J Biol Chem. 2009;284: 25569–25575.
   PubMed Web of Science ®Google Scholar
• Huang H, Park PH, McMullen MR, Mechanisms for the anti-inflammatory effects of adiponectin in macro- phages. J Gastroenterol Hepatol. 2008;23(Suppl. 1):S50–S53.
   Google Scholar
• Wolf AM, Wolf D, Avila MA, Up-regulation of the anti-inflammatory adipokine adiponectin in acute liver failure in mice. J Hepatol. 2006;44:537–543.
   PubMed Web of Science ®Google Scholar